Robert R. Conley, MD
- 18Articles
- 47.6KReads1
- 1997–2012Active
- 67Collaborators
- 163Citations2
About
Robert R. Conley, MD, has published extensively on schizophrenia and schizoaffective disorders, focusing on pharmacogenomics, antipsychotic treatment algorithms, and metabolic effects associated with atypical antipsychotics. His work includes studies on gene variants related to antipsychotic response, cardiovascular mortality in chronic schizophrenia, and guidelines for long-acting injectable antipsychotics. Conley's research also addresses neurological and genetic aspects, as well as metabolic and weight-related outcomes in psychiatric populations.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
